The cardiovascular science community has pursued the quest to identify vulnerable atherosclerotic plaque in patients for decades, hoping to prevent acute coronary events. However, despite major advancements in imaging technology that allow visualization of rupture-prone plaques, clinical studies have not demonstrated improved risk prediction compared with traditional approaches. Considering the complex relationship between plaque rupture and acute coronary event risk suggested by pathology studies and confirmed by clinical investigations, these results are not surprising. This review summarizes the evidence supporting a multifaceted hypothesis of the natural history of atherosclerotic plaque rupture.
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Managing patients at risk of acute coronary events mandates a greater focus on the atherosclerotic disease burden rather Strategies to prevent acute coronary events and their sequelae are among our most important public health priorities (2) . Identifying patients at increased risk of acute coronary events who may benefit from intensified preventative measures is a major, ongoing challenge (2) . Numerous factors (e.g., dyslipidemia, diabetes, and others), are associated with increased rates of adverse events; however, their hazard rates are too small for accurate individual risk assessments (3) . The DIAD (Detection of Ischemia in Asymptomatic Diabetics) trial revealed that after 4.8 years of follow-up, 97% of asymptomatic patients with diabetes mellitus remained free of myocardial infarction and cardiac death (4) . Even when combined as comprehensive risk scores (e.g., by the Framingham study [5] ), predictive accuracy is insufficient for adequate individual risk assessments, leading to substantial overtreatment and undertreatment, with associated morbidity and societal costs (6) .
The mechanisms leading to adverse events from atherosclerotic disease are clearly more complex than initially assumed, explaining our difficulties in accurately predicting events in individuals (7, 8) . In addition to the presence, extent, and metabolic activity of atherosclerotic disease, individual adaptations and responses to thrombogenic stimulation from altered vascular function are critical for determining the risk of acute coronary events (7, 9) . Despite a consensus on the complexity of acute coronary event risk evaluation and the necessity for comprehensive patient assessment (10, 11) , recent efforts to identify high-risk patients have focused on using advanced imaging methods to detect single "vulnerable" atherosclerotic plaques (12) . This narrow focus neglects the complexity of the processes leading to risk and lacks supporting evidence. In this review, we summarize the shift from conceptualizing acute coronary event risk as a simple cause-and-effect principle centered on high-risk plaques to a complex model involving numerous factors.
THE "VULNERABLE PLAQUE" CONCEPT
Pathology studies have demonstrated the common association of acute myocardial infarction with the rupture or erosion of a coronary atherosclerotic plaque (13, 14) , most frequently a thin-cap fibroatheroma (TCFA), characterized by a large lipid or necrotic core separated from the coronary arterial lumen by a thin membrane cap (15) . Thus, the identification of TCFAs in humans was assumed to signify a high risk of ensuing acute coronary events, which then might necessitate directed treatment or specific preventative measures (16) . Accordingly, enormous efforts have been undertaken to enable the identification of TCFAs and other high-risk plaque features in humans. The search term vulnerable plaque finds more than 400 current National Institutes of Health research awards totaling more than $150 million per year (17) and almost 2,000 research papers in the National Library of Medicine database. Although not all of these efforts aim to identify "vulnerable plaques," this topic is clearly central to many investigations involving large amounts of research dollars. Industry has also been keenly interested in developing technologies for the visualization of "vulnerable plaques," with progression of several catheter-based inventions, notably intravascular ultrasound (IVUS)-virtual histology, thermography, infrared spectroscopy, palpography, and optical coherence tomography (OCT) to preclinical or clinical stages (12, 18) .
LIMITATIONS OF STUDIES SUPPORTING THE HIGH-RISK ATHEROSCLEROTIC PLAQUE CONCEPT
A number of clinical investigations used various imaging tools to identify high-risk atherosclerotic plaque features in order to predict an increased risk of adverse events. In one large, prospective clinical study, PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree), rates of adverse cardiac events according to types of coronary atherosclerotic plaque were investigated in more than 600 high-risk patients studied with IVUSvirtual histology (19) . Although 596 TCFAs were identified, only repeat hospitalization for chest pain was associated with events. This was expected, given the typically larger luminal encroachment of TCFAs compared with pathological intimal thickening (the prevalent type of lesion in the study). However, the risk of myocardial infarction or sudden cardiac death related to these lesions was very low (Figure 1) . A similar study using IVUS-virtual histology (VIVA [VH-IVUS in Vulnerable Atherosclerosis]) reported nearly identical findings (20) . Studies using OCT revealed greatly detailed plaque characteristics in patients with acute coronary syndromes and other at-risk populations (21) . Similar to the information provided by IVUS, studies using OCT suggest that a larger lesion plaque burden might indicate an increased risk of acute coronary events (22) . Noninvasive imaging studies of the coronary arteries using computed tomographic angiography reported increased rates of acute coronary syndromes in patients with lowattenuation plaques (presumably high in lipid content) with external remodeling compared with those without such plaques (23) (24) (25) . Puchner et al. (26) recently reported independent prediction of acute coronary syndrome using computed tomography to 
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The Myth of the "Vulnerable Plaque" High-risk features may still be valuable as markers for disease burden or activity; however, such value has not been established.
EVIDENCE DIMINISHING THE SIGNIFICANCE OF IDENTIFYING "HIGH-RISK" PLAQUES
Despite our ability to identify atherosclerotic lesions that exhibit vulnerable characteristics using various imaging tools, clinical studies have failed to demonstrate meaningful clinical utility for plaque imaging. that identifying lesions prone to rupture will prevent acute coronary events was unrealistic. Of the many plaque ruptures occurring in patients with atherosclerotic disease, very few will trigger symptomatic events, rendering it exceedingly difficult to predict adverse outcomes associated with particular lesions.
Identifying a single TCFA or other "high-risk plaque," without considering other clinical or imaging characteristics, is unlikely to be of incremental benefit for risk prediction over established factors (e.g., the extent and distribution of atherosclerotic plaque burden), because of the low risk associated with a given individual plaque and the temporal relationship of its vulnerable characteristics.
CURRENT PARADIGM OF ACUTE CORONARY EVENT PATHOPHYSIOLOGY
Over the past few decades, clinical and laboratory investigations have led to a more complex concept of the pathophysiology of acute coronary events, involving numerous processes, many with poorly understood interactions (7, 8) . Although the occur- 
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CENTRAL ILLUSTRATION Fate of Ruptured Coronary Atherosclerotic Plaques According to Thrombotic Milieu
The hypothesized interplay of prothrombotic and thrombosis resisting and containing factors that presumably determine the outcome of a ruptured coronary atherosclerotic plaque is shown. (A) In the most common scenario, small thrombus formation associated with plaque rupture is contained and vascular occlusive thrombus is inhibited. (B) In the less common scenario of several prothrombotic factors coinciding (e.g., inflammatory state, large lesion plaque burden, vasoconstriction, circadian rheological changes), local thrombosis associated with plaque rupture cannot be contained, and clinically significant vascular thrombosis occurs, triggering an acute coronary syndrome (ACS). The constellation of factors leading to these different outcomes is unknown. Overall, strong evidence supports addressing the extent and activity of the atherosclerotic burden and thrombosis-promoting risk factors for improved patient outcomes, but there is no conclusive evidence of incremental risk reduction with lesion-specific treatment.
AREAS OF UNCERTAINTY: INFLUENCE OF STUDY POPULATION
The atherosclerotic disease burden is a powerful predictor of outcomes for patients without history of coronary artery disease, facilitated by the ease of coronary calcium scanning, which approximates the total coronary atherosclerotic disease volume (71).
However, it is infrequently performed in patients with established coronary artery disease; thus, in this population, plaque burden data are more limited. 
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IS THERE A ROLE FOR INDIVIDUAL PLAQUE IMAGING?
Coronary artery imaging has provided insights into numerous lesion characteristics, but we have yet to identify which are useful for guiding management.
Changing patterns of lesion characteristics, resulting from widespread use of lipid-modifying medications, pose an additional challenge (79) . There are promising data for characterizing coronary arterial lesions before percutaneous interventions (80, 81 
CONCLUSIONS
Despite major advancements in coronary artery imaging and identification of atherosclerotic lesion morphology associated with rupture, there is no 
